[
  {
    "id": "20251016-224503-b5466f8d",
    "createdAt": "2025-10-16T22:45:03.789Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/16/2025, 4:45:01 PM"
    },
    "articles": [
      {
        "id": 632,
        "title": "MiPLA",
        "slug": "mipla"
      }
    ],
    "markdown": "# MiPLA · #632\n\n+{\n+  \"title\": \"MiPLA\",\n+  \"index-category\": \"psychedelic; lysergamide; research-chemical\",\n+  \"drug_info\": {\n+    \"drug_name\": \"MiPLA\",\n+    \"chemical_name\": \"(6aR,9R)-N-methyl-N-isopropyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide\",\n+    \"alternative_name\": \"Lamide; Methylisopropyllysergamide; N-Methyl-N-isopropyllysergamide\",\n+    \"chemical_class\": \"Lysergamides\",\n+    \"psychoactive_class\": \"Psychedelic\",\n+    \"mechanism_of_action\": \"5-HT2A receptor partial agonist\",\n+    \"dosages\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"units\": \"ug\",\n+          \"dose_ranges\": {\n+            \"threshold\": \"50 ug\",\n+            \"light\": \"100-150 ug\",\n+            \"common\": \"150-200 ug\",\n+            \"strong\": \"200-250 ug\",\n+            \"heavy\": \"300+ ug\"\n+          }\n+        }\n+      ]\n+    },\n+    \"duration\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"stages\": {\n+            \"total_duration\": \"4-6 hours\",\n+            \"onset\": \"20-40 minutes\",\n+            \"peak\": \"1-2 hours (preceded by 45-90 minute come-up)\",\n+            \"offset\": \"1-2 hours\",\n+            \"after_effects\": \"Minimal residual stimulation\"\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n+        }\n+      ]\n+    },\n+    \"addiction_potential\": \"MiPLA is not considered physically addictive and has low potential for psychological dependence, similar to other serotonergic psychedelics. Rapid tolerance development discourages frequent use.\",\n+    \"interactions\": {\n+      \"dangerous\": [\n+        \"Lithium (significantly increases risk of psychosis and seizures)\",\n+        \"Tramadol (lowers seizure threshold)\"\n+      ],\n+      \"unsafe\": [\n+        \"Stimulants (amphetamine, cocaine, methylphenidate - increases risk of anxiety, paranoia, panic attacks, thought loops, mania, and psychosis)\"\n+      ],\n+      \"caution\": [\n+        \"Cannabis (unpredictable synergy; significantly increases risk of anxiety, paranoia, panic attacks, and psychosis)\",\n+        \"SSRIs (may alter or blunt effects)\"\n+      ]\n+    },\n+    \"notes\": \"MiPLA is a research chemical with very limited history of human use and minimal scientific study of its pharmacology, metabolism, and toxicity. It is approximately two to three times less potent than LSD and has a notably shorter duration of around 4-6 hours. The substance is generally described as producing less anxiety and a lighter headspace compared to LSD. Individuals with personal or family history of mental illness should avoid use. Use precise weighing equipment and employ harm reduction practices including careful set and setting preparation.\",\n+    \"subjective_effects\": [\n+      \"Stimulation\",\n+      \"Physical Euphoria\",\n+      \"Tactile Enhancement\",\n+      \"Visual Acuity Enhancement\",\n+      \"Color Enhancement\",\n+      \"Pattern Recognition Enhancement\",\n+      \"Visual Drifting\",\n+      \"Geometric Patterns\",\n+      \"Cognitive Euphoria\",\n+      \"Analysis Enhancement\",\n+      \"Music Appreciation Enhancement\",\n+      \"Time Distortion\",\n+      \"Ego Death (at higher doses)\",\n+      \"Nausea\",\n+      \"Increased Body Temperature\"\n+    ],\n+    \"tolerance\": {\n+      \"full_tolerance\": \"Develops almost immediately after ingestion\",\n+      \"half_tolerance\": \"5-7 days\",\n+      \"zero_tolerance\": \"14 days\",\n+      \"cross_tolerances\": [\n+        \"All psychedelics (due to 5-HT2A receptor activity)\"\n+      ]\n+    },\n+    \"half_life\": \"1-3 hours (estimated based on duration profile)\",\n+    \"citations\": [\n+      {\n+        \"name\": \"PsychonautWiki: MiPLA\",\n+        \"reference\": \"https://psychonautwiki.org/wiki/MiPLA\"\n+      },\n+      {\n+        \"name\": \"Erowid MiPLA Experience Vault\",\n+        \"reference\": \"https://erowid.org/experiences/subs/exp_MIPLA.shtml\"\n+      },\n+      {\n+        \"name\": \"Bluelight: The Big & Dandy MIPLA Thread\",\n+        \"reference\": \"https://www.bluelight.org/community/threads/the-big-dandy-mipla-methylisopropyllysergamide-thread.784440/\"\n+      },\n+      {\n+        \"name\": \"Isomer Design: MiPLA (PiHKAL)\",\n+        \"reference\": \"https://isomerdesign.com/pihkal/explore/5327\"\n+      },\n+      {\n+        \"name\": \"Halberstadt et al. (2018) - Pharmacological characterization of ECPLA\",\n+        \"reference\": \"https://link.springer.com/article/10.1007/s00213-018-5055-9\"\n+      },\n+      {\n+        \"name\": \"Nichols, D.E. (2001) - LSD and its lysergamide cousins\",\n+        \"reference\": \"The Heffter Review of Psychedelic Research, Vol. 2, pp. 80-87\"\n+      }\n+    ],\n+    \"categories\": [\n+      \"psychedelic\",\n+      \"lysergamide\",\n+      \"research-chemical\"\n+    ]\n+  },\n+  \"id\": 632\n+}",
    "submittedBy": "JOSIE"
  },
  {
    "id": "20251016-223851-15e5eaa2",
    "createdAt": "2025-10-16T22:38:51.510Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/16/2025, 4:38:49 PM"
    },
    "articles": [
      {
        "id": 631,
        "title": "LSA",
        "slug": "lsa"
      }
    ],
    "markdown": "# LSA · #631\n\n+{\n+  \"title\": \"LSA\",\n+  \"index-category\": \"psychedelic; natural\",\n+  \"drug_info\": {\n+    \"drug_name\": \"LSA\",\n+    \"chemical_name\": \"(8β)-9,10-Didehydro-6-methyl-ergoline-8-carboxamide\",\n+    \"alternative_name\": \"Ergine; d-Lysergic acid amide; d-Lysergamide; LA-111\",\n+    \"chemical_class\": \"Lysergamide; Ergoline alkaloid\",\n+    \"psychoactive_class\": \"Psychedelic\",\n+    \"mechanism_of_action\": \"5-HT2A receptor partial agonist\",\n+    \"dosages\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral (morning glory seeds)\",\n+          \"units\": \"seeds\",\n+          \"dose_ranges\": {\n+            \"threshold\": \"20-50 seeds\",\n+            \"light\": \"50-100 seeds\",\n+            \"common\": \"100-250 seeds\",\n+            \"strong\": \"250-400 seeds\",\n+            \"heavy\": \"400+ seeds\"\n+          }\n+        },\n+        {\n+          \"route\": \"oral (hawaiian baby woodrose seeds)\",\n+          \"units\": \"seeds\",\n+          \"dose_ranges\": {\n+            \"threshold\": \"1-3 seeds\",\n+            \"light\": \"3-5 seeds\",\n+            \"common\": \"5-7 seeds\",\n+            \"strong\": \"7-12 seeds\",\n+            \"heavy\": \"12+ seeds\"\n+          }\n+        },\n+        {\n+          \"route\": \"oral (pure lsa)\",\n+          \"units\": \"mg\",\n+          \"dose_ranges\": {\n+            \"threshold\": \"0.5 mg\",\n+            \"light\": \"0.5-1 mg\",\n+            \"common\": \"1-2 mg\",\n+            \"strong\": \"2-3 mg\",\n+            \"heavy\": \"3+ mg\"\n+          }\n+        }\n+      ]\n+    },\n+    \"duration\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral (morning glory seeds)\",\n+          \"stages\": {\n+            \"total_duration\": \"4-10 hours\",\n+            \"onset\": \"20-60 minutes (up to 3 hours reported)\",\n+            \"peak\": \"90-180 minutes\",\n+            \"offset\": \"2-7 hours\",\n+            \"after_effects\": \"1-12 hours (afterglow)\"\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n+        },\n+        {\n+          \"route\": \"oral (hawaiian baby woodrose seeds)\",\n+          \"stages\": {\n+            \"total_duration\": \"4-10 hours\",\n+            \"onset\": \"20-60 minutes (up to 3 hours reported)\",\n+            \"peak\": \"90-180 minutes\",\n+            \"offset\": \"2-7 hours\",\n+            \"after_effects\": \"1-12 hours (afterglow)\"\n+          }\n+        },\n+        {\n+          \"route\": \"oral (pure lsa)\",\n+          \"stages\": {\n+            \"total_duration\": \"4-10 hours\",\n+            \"onset\": \"20-60 minutes (up to 3 hours reported)\",\n+            \"peak\": \"90-180 minutes\",\n+            \"offset\": \"2-7 hours\",\n+            \"after_effects\": \"1-12 hours (afterglow)\"\n+          }\n+        }\n+      ]\n+    },\n+    \"addiction_potential\": \"LSA is not considered to be addictive with low abuse potential. There is virtually no withdrawal syndrome when use is stopped, and animal studies have not demonstrated self-administration behavior predictive of abuse liability.\",\n+    \"interactions\": {\n+      \"dangerous\": [\n+        \"Lithium (significantly increased risk of psychosis and seizures)\",\n+        \"Tramadol (lowers seizure threshold)\"\n+      ],\n+      \"unsafe\": [\n+        \"Stimulants (increased risk of anxiety, paranoia, thought loops, and mania)\",\n+        \"Cannabis (unexpectedly strong and unpredictable synergy; significantly increases risk of anxiety, paranoia, panic attacks, and psychosis)\"\n+      ],\n+      \"caution\": [\n+        \"SSRIs (may suppress visual and cognitive effects)\",\n+        \"MAOIs (may potentiate effects; use caution with potential for dangerous interactions with other substances)\",\n+        \"Dissociatives (greatly enhance cognitive, visual and hallucinatory effects with increased risk of confusion and psychosis)\",\n+        \"Alcohol (may reduce anxiety but can increase dehydration, nausea and physical fatigue)\",\n+        \"Benzodiazepines (can reduce trip intensity; useful for stopping bad trips but may cause amnesia)\",\n+        \"Other psychedelics (unpredictable synergy and intensification of effects)\"\n+      ]\n+    },\n+    \"notes\": \"LSA-containing seeds vary widely in alkaloid content between species, batches, and individual seeds. Commercial seeds are often treated with fungicides or pesticides that can be extremely toxic; only use organic, untreated seeds from trusted vendors. Heavy metal testing is recommended before consumption. Extraction methods can significantly reduce nausea and body load. Strong vasoconstriction is common and can cause painful leg cramping; avoid repeated use over short periods. Set and setting strongly influence the experience. Individuals with personal or family histories of psychotic disorders should avoid use.\",\n+    \"subjective_effects\": [\n+      \"Sedation (setting-dependent)\",\n+      \"Physical Euphoria\",\n+      \"Visual Enhancements and Distortions\",\n+      \"Spontaneous Bodily Sensations\",\n+      \"Perception of Bodily Heaviness\",\n+      \"Motor Control Loss\",\n+      \"Nausea and Vasoconstriction\",\n+      \"Dream-Like State\",\n+      \"Introspection and Analysis Enhancement\",\n+      \"Emotion Enhancement\",\n+      \"Time Distortion\",\n+      \"Internal and External Hallucinations\",\n+      \"Thought Connectivity\",\n+      \"Music Appreciation Enhancement\",\n+      \"Spirituality Enhancement\"\n+    ],\n+    \"tolerance\": {\n+      \"full_tolerance\": \"Almost immediately after ingestion\",\n+      \"half_tolerance\": \"3-4 days\",\n+      \"zero_tolerance\": \"7 days\",\n+      \"cross_tolerances\": [\n+        \"All psychedelics (LSD, psilocybin mushrooms, mescaline, DMT, 2C-x compounds)\"\n+      ]\n+    },\n+    \"half_life\": \"1-3 hours (psilocin is referenced in the original document, but LSA half-life data is limited; serum concentrations detectable for 1-24 hours post-ingestion)\",\n+    \"citations\": [\n+      {\n+        \"name\": \"PsychonautWiki: LSA\",\n+        \"reference\": \"https://psychonautwiki.org/wiki/LSA\"\n+      },\n+      {\n+        \"name\": \"TripSit Wiki: LSA\",\n+        \"reference\": \"https://wiki.tripsit.me/wiki/LSA\"\n+      },\n+      {\n+        \"name\": \"Erowid LSA Vault\",\n+        \"reference\": \"https://www.erowid.org/chemicals/lsa/lsa.shtml\"\n+      },\n+      {\n+        \"name\": \"Erowid LSA Dosage\",\n+        \"reference\": \"https://erowid.org/chemicals/lsa/lsa_dose.shtml\"\n+      },\n+      {\n+        \"name\": \"Erowid LSA Effects\",\n+        \"reference\": \"https://www.erowid.org/chemicals/lsa/lsa_effects.shtml\"\n+      },\n+      {\n+        \"name\": \"Bluelight: The Big & Dandy LSA Thread\",\n+        \"reference\": \"https://www.bluelight.org/community/threads/lsas-subthread-extraction-of-lsas.123944/\"\n+      },\n+      {\n+        \"name\": \"Drugs-Forum: LSA Wiki\",\n+        \"reference\": \"https://drugs-forum.com/wiki/LSA\"\n+      },\n+      {\n+        \"name\": \"Wikipedia: Ergine\",\n+        \"reference\": \"https://en.wikipedia.org/wiki/Ergine\"\n+      },\n+      {\n+        \"name\": \"Lysergic Acid Amide (LSA), an LSD Analog: Systematic Review (MDPI, 2025)\",\n+        \"reference\": \"https://www.mdpi.com/2226-4787/13/4/98\"\n+      }\n+    ],\n+    \"categories\": [\n+      \"psychedelic\",\n+      \"lysergamide\",\n+      \"natural\",\n+      \"ergoline\"\n+    ]\n+  },\n+  \"id\": 631\n+}",
    "submittedBy": "JOSIE"
  },
  {
    "id": "20251016-223526-fd17483e",
    "createdAt": "2025-10-16T22:35:26.906Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/16/2025, 4:35:25 PM"
    },
    "articles": [
      {
        "id": 630,
        "title": "ETH-LAD",
        "slug": "eth-lad"
      }
    ],
    "markdown": "# ETH-LAD · #630\n\n+{\n+  \"title\": \"ETH-LAD\",\n+  \"index-category\": \"psychedelic; lysergamide\",\n+  \"drug_info\": {\n+    \"drug_name\": \"ETH-LAD\",\n+    \"chemical_name\": \"(6aR,9R)-N,N,7-Triethyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide\",\n+    \"alternative_name\": \"N-Ethyl-nor-LSD; 6-Ethyl-6-nor-lysergic acid diethylamide; N-Ethyl-nor-lysergic acid N,N-diethylamide\",\n+    \"chemical_class\": \"Lysergamides\",\n+    \"psychoactive_class\": \"Psychedelic\",\n+    \"mechanism_of_action\": \"5-HT2A receptor agonist; 5-HT2C receptor agonist; 5-HT1A receptor agonist (high affinity); dopamine D1, D2, D3, D4, D5 receptor binding (lower affinity)\",\n+    \"dosages\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"units\": \"ug\",\n+          \"dose_ranges\": {\n+            \"threshold\": \"15 ug\",\n+            \"light\": \"30-60 ug\",\n+            \"common\": \"60-150 ug\",\n+            \"strong\": \"150-225 ug\",\n+            \"heavy\": \"225+ ug\"\n+          }\n+        }\n+      ]\n+    },\n+    \"duration\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"stages\": {\n+            \"total_duration\": \"8-12 hours\",\n+            \"onset\": \"20-40 minutes\",\n+            \"peak\": \"4-6 hours (including 45-90 minute come up)\",\n+            \"offset\": \"2-4 hours\",\n+            \"after_effects\": \"8-48 hours\"\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n+        }\n+      ]\n+    },\n+    \"addiction_potential\": \"ETH-LAD is not considered habit-forming and demonstrates a self-regulating quality typical of psychedelics. Rapid tolerance develops immediately after use, discouraging frequent consumption. Cases of abuse have been rarely reported, though the substance generally decreases in desirability with repeated use.\",\n+    \"interactions\": {\n+      \"dangerous\": [\n+        \"Lithium (significantly increased risk of psychosis and seizures)\",\n+        \"Tramadol (lowers seizure threshold)\"\n+      ],\n+      \"unsafe\": [\n+        \"Cannabis (unpredictable and strongly increased effects, risk of anxiety, paranoia, panic attacks, and psychosis)\",\n+        \"Stimulants including amphetamine, cocaine, methylphenidate (increased risk of anxiety, paranoia, panic attacks, thought loops, mania, and psychosis)\"\n+      ],\n+      \"caution\": []\n+    },\n+    \"notes\": \"ETH-LAD requires exceptional caution due to its high potency, unpredictable dose-response curve, and tendency to produce severe physical side effects including pronounced nausea, temperature dysregulation, muscle cramps, and bodily discomfort at higher doses. The substance is notably more difficult to handle than LSD and should only be used by experienced psychedelic users. Accurate measurement with a precise scale is critical. Users should monitor body temperature throughout the experience and maintain access to climate control. Set and setting are paramount, and having a trusted sober sitter is strongly recommended, especially at doses above the common range. Individuals with personal or family history of psychotic disorders should avoid use.\",\n+    \"subjective_effects\": [\n+      \"Intricate Visual Geometry\",\n+      \"Enhanced Pattern Recognition\",\n+      \"Auditory Distortions and Hallucinations\",\n+      \"Analysis Enhancement\",\n+      \"Introspective Thought Patterns\",\n+      \"Time Distortion\",\n+      \"Synaesthesia\",\n+      \"Enhanced Color Perception\",\n+      \"Nausea and Bodily Discomfort\",\n+      \"Temperature Dysregulation\",\n+      \"Emotional Neutrality or Detachment\",\n+      \"Thought Acceleration\",\n+      \"Memory Suppression\"\n+    ],\n+    \"tolerance\": {\n+      \"full_tolerance\": \"Develops almost immediately after ingestion\",\n+      \"half_tolerance\": \"5-7 days\",\n+      \"zero_tolerance\": \"14 days\",\n+      \"cross_tolerances\": [\n+        \"All psychedelics including LSD, psilocybin, mescaline, DMT, and related lysergamides\"\n+      ]\n+    },\n+    \"half_life\": \"\",\n+    \"citations\": [\n+      {\n+        \"name\": \"Bluelight: The Big & Dandy ETH-LAD Thread\",\n+        \"reference\": \"https://bluelight.org/xf/threads/the-big-dandy-eth-lad-thread.761505/\"\n+      },\n+      {\n+        \"name\": \"Erowid ETH-LAD Experience Vault\",\n+        \"reference\": \"https://www.erowid.org/experiences/subs/exp_ETHLAD.shtml\"\n+      },\n+      {\n+        \"name\": \"Erowid TiHKAL Entry #12: ETH-LAD\",\n+        \"reference\": \"https://erowid.org/library/books_online/tihkal/tihkal12.shtml\"\n+      },\n+      {\n+        \"name\": \"Hoffman AJ, Nichols DE (1985) - Synthesis and LSD-like discriminative stimulus properties\",\n+        \"reference\": \"https://doi.org/10.1021/jm00147a022\"\n+      },\n+      {\n+        \"name\": \"Isomer Design: TiHKAL ETH-LAD Entry\",\n+        \"reference\": \"http://isomerdesign.com/PiHKAL/read.php?domain=tk&id=12\"\n+      },\n+      {\n+        \"name\": \"PsychonautWiki: ETH-LAD\",\n+        \"reference\": \"https://psychonautwiki.org/wiki/ETH-LAD\"\n+      }\n+    ],\n+    \"categories\": [\n+      \"psychedelic\",\n+      \"lysergamide\",\n+      \"research-chemical\"\n+    ]\n+  },\n+  \"id\": 630\n+}",
    "submittedBy": "JOSIE"
  },
  {
    "id": "20251016-223152-65eead67",
    "createdAt": "2025-10-16T22:31:52.581Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/16/2025, 4:31:51 PM"
    },
    "articles": [
      {
        "id": 629,
        "title": "ALD-52",
        "slug": "ald-52"
      }
    ],
    "markdown": "# ALD-52 · #629\n\n+{\n+  \"title\": \"ALD-52\",\n+  \"index-category\": \"psychedelic; lysergamide\",\n+  \"drug_info\": {\n+    \"drug_name\": \"ALD-52\",\n+    \"chemical_name\": \"(6aR,9R)-4-Acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]-quinoline-9-carboxamide\",\n+    \"alternative_name\": \"1-Acetyl-LSD; 1A-LSD; 1A-LAD; Orange Sunshine\",\n+    \"chemical_class\": \"Lysergamides\",\n+    \"psychoactive_class\": \"Psychedelic\",\n+    \"mechanism_of_action\": \"5-HT2A receptor partial agonist; 5-HT2C receptor partial agonist; 5-HT1A receptor partial agonist; D2 receptor agonist (through LSD metabolite)\",\n+    \"dosages\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"units\": \"ug\",\n+          \"dose_ranges\": {\n+            \"threshold\": \"30 ug\",\n+            \"light\": \"30-100 ug\",\n+            \"common\": \"100-175 ug\",\n+            \"strong\": \"175-325 ug\",\n+            \"heavy\": \"325+ ug\"\n+          }\n+        }\n+      ]\n+    },\n+    \"duration\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"stages\": {\n+            \"total_duration\": \"8-14 hours\",\n+            \"onset\": \"20-40 minutes\",\n+            \"peak\": \"3-5 hours (following 1-2 hour come up)\",\n+            \"offset\": \"3-5 hours\",\n+            \"after_effects\": \"4-24 hours\"\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n+        }\n+      ]\n+    },\n+    \"addiction_potential\": \"ALD-52 is not considered physically addictive and has extremely low potential for psychological dependence. The rapid development of tolerance discourages frequent use patterns, and the desire to use typically decreases with repeated exposure rather than increasing.\",\n+    \"interactions\": {\n+      \"dangerous\": [\n+        \"Lithium (significantly increases risk of psychosis and seizures)\",\n+        \"MAOIs (unpredictable effects, possible hypertensive reaction)\"\n+      ],\n+      \"unsafe\": [\n+        \"Tramadol (lowers seizure threshold, psychedelics may trigger seizures)\",\n+        \"Stimulants including amphetamines and cocaine (increased risk of anxiety, thought loops, cardiovascular strain)\"\n+      ],\n+      \"caution\": [\n+        \"Cannabis (unpredictably strong synergy, increased risk of anxiety and paranoia)\",\n+        \"MDMA (may increase neurotoxicity, unpredictable synergy)\",\n+        \"Other psychedelics (intense cross-tolerance and potentially overwhelming effects)\",\n+        \"SSRIs (may blunt or alter effects)\"\n+      ]\n+    },\n+    \"notes\": \"ALD-52 functions as a prodrug for LSD, metabolizing into LSD in the body along with other metabolites. Legal status varies widely by jurisdiction; it is controlled in many countries including the UK, Germany, Switzerland, and Latvia, while remaining technically unscheduled in others such as the United States and Denmark. Individuals with personal or family history of psychotic disorders should avoid use. Famous for being mistakenly associated with 'Orange Sunshine' LSD from the 1960s, though this was later confirmed to be standard LSD at 300 micrograms per dose. Set and setting are critical for a positive experience, and users should approach this potent, long-lasting substance with proper preparation and harm reduction practices.\",\n+    \"subjective_effects\": [\n+      \"Visual Patterning And Geometry\",\n+      \"Enhanced Sensory Perception\",\n+      \"Time Distortion\",\n+      \"Cognitive Euphoria\",\n+      \"Enhanced Introspection\",\n+      \"Emotional Amplification\",\n+      \"Physical Euphoria\",\n+      \"Thought Acceleration\",\n+      \"Enhanced Music Appreciation\",\n+      \"Pupil Dilation\",\n+      \"Increased Energy And Stimulation\",\n+      \"Novel Thought Patterns\"\n+    ],\n+    \"tolerance\": {\n+      \"full_tolerance\": \"Immediately after ingestion, cross-tolerant with all psychedelics\",\n+      \"half_tolerance\": \"5-7 days\",\n+      \"zero_tolerance\": \"14 days\",\n+      \"cross_tolerances\": [\n+        \"All psychedelics including LSD, psilocybin mushrooms, mescaline, and tryptamines\"\n+      ]\n+    },\n+    \"half_life\": \"1-3 hours (LSD active metabolite)\",\n+    \"citations\": [\n+      {\n+        \"name\": \"Erowid ALD-52 Vault\",\n+        \"reference\": \"https://erowid.org/chemicals/lsd/lsd_ald52.shtml\"\n+      },\n+      {\n+        \"name\": \"Isomer Design TiHKAL Entry 26 (LSD)\",\n+        \"reference\": \"https://isomerdesign.com/pihkal/read/tk/26\"\n+      },\n+      {\n+        \"name\": \"PsychonautWiki: ALD-52\",\n+        \"reference\": \"https://psychonautwiki.org/wiki/ALD-52\"\n+      },\n+      {\n+        \"name\": \"The Big & Dandy ALD-52 Thread (Bluelight)\",\n+        \"reference\": \"https://www.bluelight.org/community/threads/the-big-dandy-ald-52-thread.773316/\"\n+      },\n+      {\n+        \"name\": \"TripSit Drug Combination Chart\",\n+        \"reference\": \"https://wiki.tripsit.me/wiki/Drug_combinations\"\n+      },\n+      {\n+        \"name\": \"Wagmann et al. (2019) In vitro metabolic fate of nine LSD-based new psychoactive substances\",\n+        \"reference\": \"https://doi.org/10.1007/s00216-018-1558-9\"\n+      }\n+    ],\n+    \"categories\": [\n+      \"psychedelic\",\n+      \"lysergamide\",\n+      \"research-chemical\",\n+      \"prodrug\"\n+    ]\n+  },\n+  \"id\": 629\n+}",
    "submittedBy": "JOSIE"
  },
  {
    "id": "20251016-222911-e7a3cfaa",
    "createdAt": "2025-10-16T22:29:11.119Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/16/2025, 4:29:09 PM"
    },
    "articles": [
      {
        "id": 628,
        "title": "1V-LSD",
        "slug": "1v-lsd"
      }
    ],
    "markdown": "# 1V-LSD · #628\n\n+{\n+  \"title\": \"1V-LSD\",\n+  \"index-category\": \"psychedelic; research-chemical\",\n+  \"drug_info\": {\n+    \"drug_name\": \"1V-LSD\",\n+    \"chemical_name\": \"1-Valeroyl-d-lysergic acid diethylamide\",\n+    \"alternative_name\": \"Valerie; 1-Valeryl-LSD; 1-Pentanoyl-LSD\",\n+    \"chemical_class\": \"Lysergamides\",\n+    \"psychoactive_class\": \"Psychedelic\",\n+    \"mechanism_of_action\": \"5-HT2A receptor partial agonist (weak); acts as prodrug for LSD via deacylation\",\n+    \"dosages\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"units\": \"ug\",\n+          \"dose_ranges\": {\n+            \"threshold\": \"15 ug\",\n+            \"light\": \"25-75 ug\",\n+            \"common\": \"75-150 ug\",\n+            \"strong\": \"150-300 ug\",\n+            \"heavy\": \"300+ ug\"\n+          }\n+        }\n+      ]\n+    },\n+    \"duration\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"stages\": {\n+            \"total_duration\": \"8-12 hours\",\n+            \"onset\": \"20-60 minutes\",\n+            \"peak\": \"3-5 hours (come up 45-120 minutes)\",\n+            \"offset\": \"3-5 hours\",\n+            \"after_effects\": \"6-24 hours\"\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n+        }\n+      ]\n+    },\n+    \"addiction_potential\": \"1V-LSD is assumed to be non-addictive with low abuse potential, similar to LSD. No literature reports exist of successful attempts to train animals to self-administer LSD analogs. There is virtually no withdrawal syndrome when chronic use is stopped.\",\n+    \"interactions\": {\n+      \"dangerous\": [\n+        \"Lithium (significantly increases risk of psychosis and seizures)\",\n+        \"Tramadol (lowers seizure threshold)\"\n+      ],\n+      \"unsafe\": [\n+        \"Cannabis (strong synergy, significantly increases risk of anxiety, paranoia, panic attacks, and psychosis)\"\n+      ],\n+      \"caution\": [\n+        \"Stimulants (may increase risk of anxiety, paranoia, panic attacks, thought loops, mania and psychosis)\",\n+        \"MDMA (unpredictable synergy, potential increased neurotoxicity)\",\n+        \"Dissociatives (enhanced hallucinatory effects, increased risk of confusion and delusions)\",\n+        \"Benzodiazepines (reduce intensity of effects)\",\n+        \"Alcohol (may reduce anxiety but causes dehydration and physical discomfort)\"\n+      ]\n+    },\n+    \"notes\": \"1V-LSD is a novel research chemical with minimal history of human use and unverified safety profile. It is presumed to act as a prodrug for LSD. Those with personal or family history of mental illness should avoid use, particularly outside supervised medical settings. Set and setting are critical factors in determining experience quality. Start with lower doses due to individual variations in body weight, tolerance, metabolism, and sensitivity. No toxic dose is known, but higher doses increase risk of adverse psychological reactions. Test substances with reagent kits, though Ehrlich's reagent reacts slowly with N-acylated lysergamides.\",\n+    \"subjective_effects\": [\n+      \"Geometric Visual Hallucinations\",\n+      \"Time Distortion\",\n+      \"Enhanced Introspection\",\n+      \"Ego Loss\",\n+      \"Stimulation\",\n+      \"Spontaneous Bodily Sensations\",\n+      \"Physical Euphoria\",\n+      \"Tactile Enhancement\",\n+      \"Color Enhancement\",\n+      \"Pattern Recognition Enhancement\",\n+      \"Visual Drifting\",\n+      \"Analysis Enhancement\",\n+      \"Conceptual Thinking\",\n+      \"Emotion Enhancement\",\n+      \"Cognitive Euphoria\",\n+      \"Creativity Enhancement\",\n+      \"Increased Music Appreciation\",\n+      \"Unity And Interconnectedness\"\n+    ],\n+    \"tolerance\": {\n+      \"full_tolerance\": \"Builds almost immediately after ingestion\",\n+      \"half_tolerance\": \"5-7 days\",\n+      \"zero_tolerance\": \"14 days\",\n+      \"cross_tolerances\": [\n+        \"All psychedelics (including LSD, psilocybin, mescaline, DMT)\"\n+      ]\n+    },\n+    \"half_life\": \"Similar to LSD (estimated 3-5 hours for active metabolite)\",\n+    \"citations\": [\n+      {\n+        \"name\": \"PsychonautWiki: 1V-LSD\",\n+        \"reference\": \"https://psychonautwiki.org/wiki/1V-LSD\"\n+      },\n+      {\n+        \"name\": \"Erowid 1V-LSD Experience Vault\",\n+        \"reference\": \"https://www.erowid.org/experiences/subs/exp_1VLSD.shtml\"\n+      },\n+      {\n+        \"name\": \"Bluelight: The Small & Handy 1V-LSD Thread\",\n+        \"reference\": \"https://bluelight.org/xf/threads/the-small-handy-1v-lsd-thread.904997/\"\n+      },\n+      {\n+        \"name\": \"Brandt et al. (2022): Return of the lysergamides Part VII - Analytical and behavioural characterization of 1V-LSD\",\n+        \"reference\": \"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/dta.3205\"\n+      },\n+      {\n+        \"name\": \"Tripsitter: 1V-LSD - A New LSD Analog\",\n+        \"reference\": \"https://tripsitter.com/1v-lsd/\"\n+      }\n+    ],\n+    \"categories\": [\n+      \"psychedelic\",\n+      \"lysergamide\",\n+      \"research-chemical\",\n+      \"prodrug\"\n+    ]\n+  },\n+  \"id\": 628\n+}",
    "submittedBy": "JOSIE"
  },
  {
    "id": "20251016-222618-76ba04c5",
    "createdAt": "2025-10-16T22:26:18.516Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/16/2025, 4:26:16 PM"
    },
    "articles": [
      {
        "id": 626,
        "title": "Diphenhydramine",
        "slug": "diphenhydramine"
      },
      {
        "id": 627,
        "title": "Diphenhydramine",
        "slug": "diphenhydramine"
      }
    ],
    "markdown": "# Diphenhydramine · #626\n\n+{\n+  \"title\": \"Diphenhydramine\",\n+  \"index-category\": \"deliriant; otc\",\n+  \"drug_info\": {\n+    \"drug_name\": \"Diphenhydramine\",\n+    \"chemical_name\": \"2-(Diphenylmethoxy)-N,N-dimethylethanamine\",\n+    \"alternative_name\": \"DPH; Benadryl; Nytol; Sominex; Unisom SleepMelts; ZzzQuil; Dimedrol\",\n+    \"chemical_class\": \"Ethanolamine\",\n+    \"psychoactive_class\": \"Deliriant\",\n+    \"mechanism_of_action\": \"H1 histamine receptor inverse agonist; muscarinic acetylcholine receptor antagonist; weak serotonin reuptake inhibition; sodium channel blockade; voltage-gated potassium channel blockade\",\n+    \"dosages\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"units\": \"mg\",\n+          \"dose_ranges\": {\n+            \"threshold\": \"25 mg\",\n+            \"light\": \"100-200 mg\",\n+            \"common\": \"200-400 mg\",\n+            \"strong\": \"400-700 mg\",\n+            \"heavy\": \"700+ mg\"\n+          }\n+        }\n+      ]\n+    },\n+    \"duration\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"stages\": {\n+            \"total_duration\": \"3-10 hours\",\n+            \"onset\": \"30-90 minutes\",\n+            \"peak\": \"1-4 hours\",\n+            \"offset\": \"2-6 hours\",\n+            \"after_effects\": \"Up to 24 hours\"\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n+        }\n+      ]\n+    },\n+    \"addiction_potential\": \"Diphenhydramine has low abuse potential due to its overwhelmingly dysphoric and unpleasant effects. While physical dependence is possible with chronic use, most users do not wish to repeat the experience. Tolerance develops rapidly with repeated use.\",\n+    \"interactions\": {\n+      \"dangerous\": [\n+        \"MAOIs (risk of severe anticholinergic effects)\",\n+        \"Anticholinergics (severe tachycardia, heart attack risk, abnormal heart rhythm)\",\n+        \"High doses of acetaminophen-containing formulations (liver damage, death)\"\n+      ],\n+      \"unsafe\": [\n+        \"Stimulants (severe tachycardia, heart attack risk, abnormal heart rhythm)\",\n+        \"Tramadol (increased seizure risk)\",\n+        \"Alcohol (dangerous sedation, respiratory depression)\"\n+      ],\n+      \"caution\": [\n+        \"Benzodiazepines (dangerous sedation, respiratory depression, visual suppression)\",\n+        \"SSRIs (visual suppression, potential serotonin syndrome)\",\n+        \"Opioids (increased sedation, respiratory depression)\"\n+      ]\n+    },\n+    \"notes\": \"Diphenhydramine is widely available over-the-counter and used medically for allergies and sleep aid. Recreational use produces intensely dysphoric and unpredictable deliriant effects including realistic hallucinations that users cannot distinguish from reality. The substance has significant cardiovascular risks including QT prolongation and potential for torsades de pointes. Always verify that products contain only diphenhydramine as active ingredient; many combination products contain acetaminophen or other drugs that can be fatal in high doses. A sober trip sitter is essential as users may respond to hallucinations and injure themselves. Chronic use may cause persistent cognitive impairment, memory damage, and has been linked to increased dementia risk.\",\n+    \"subjective_effects\": [\n+      \"Sedation and Body Heaviness\",\n+      \"External Hallucinations (People, Objects, Insects)\",\n+      \"Auditory Hallucinations (Voices, Screams)\",\n+      \"Tactile Hallucinations (Phantom Sensations)\",\n+      \"Shadow People\",\n+      \"Delirium and Confusion\",\n+      \"Memory Suppression and Amnesia\",\n+      \"Dysphoria and Anxiety\",\n+      \"Restless Leg Syndrome\",\n+      \"Dry Mouth and Dehydration\",\n+      \"Visual Acuity Suppression (Blurred Vision)\",\n+      \"Thought Disorganization\"\n+    ],\n+    \"tolerance\": {\n+      \"full_tolerance\": \"After 2-3 consecutive days of use\",\n+      \"half_tolerance\": \"3-5 days\",\n+      \"zero_tolerance\": \"1-2 weeks\",\n+      \"cross_tolerances\": [\n+        \"All deliriants (datura, scopolamine, dimenhydrinate)\"\n+      ]\n+    },\n+    \"half_life\": \"5 hours (pediatric); 9 hours (adult); 13.5 hours (elderly)\",\n+    \"citations\": [\n+      {\n+        \"name\": \"Erowid Diphenhydramine Vault\",\n+        \"reference\": \"https://www.erowid.org/pharms/diphenhydramine/\"\n+      },\n+      {\n+        \"name\": \"PsychonautWiki: Diphenhydramine\",\n+        \"reference\": \"https://psychonautwiki.org/wiki/Diphenhydramine\"\n+      },\n+      {\n+        \"name\": \"TripSit Wiki: Diphenhydramine\",\n+        \"reference\": \"https://wiki.tripsit.me/wiki/Diphenhydramine\"\n+      },\n+      {\n+        \"name\": \"Bluelight: Diphenhydramine Discussion\",\n+        \"reference\": \"https://www.bluelight.org/community/threads/dph-trip.560305/\"\n+      },\n+      {\n+        \"name\": \"DrugBank: Diphenhydramine\",\n+        \"reference\": \"https://go.drugbank.com/drugs/DB01075\"\n+      },\n+      {\n+        \"name\": \"StatPearls: Diphenhydramine Toxicity\",\n+        \"reference\": \"https://www.ncbi.nlm.nih.gov/books/NBK557578/\"\n+      },\n+      {\n+        \"name\": \"Gray et al., 2015 - Cumulative Anticholinergic Use and Dementia\",\n+        \"reference\": \"https://pubmed.ncbi.nlm.nih.gov/25621434/\"\n+      }\n+    ],\n+    \"categories\": [\n+      \"deliriant\",\n+      \"depressant\",\n+      \"antihistamine\",\n+      \"otc\"\n+    ]\n+  },\n+  \"id\": 626\n+}\n\n# Diphenhydramine · #627\n\n+{\n+  \"title\": \"Diphenhydramine\",\n+  \"index-category\": \"deliriant; otc\",\n+  \"drug_info\": {\n+    \"drug_name\": \"Diphenhydramine\",\n+    \"chemical_name\": \"2-(Diphenylmethoxy)-N,N-dimethylethanamine\",\n+    \"alternative_name\": \"DPH; Benadryl; Nytol; Sominex; Unisom SleepMelts; ZzzQuil; Dimedrol\",\n+    \"chemical_class\": \"Ethanolamine\",\n+    \"psychoactive_class\": \"Deliriant\",\n+    \"mechanism_of_action\": \"H1 histamine receptor inverse agonist; muscarinic acetylcholine receptor antagonist; weak serotonin reuptake inhibition; sodium channel blockade; voltage-gated potassium channel blockade\",\n+    \"dosages\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"units\": \"mg\",\n+          \"dose_ranges\": {\n+            \"threshold\": \"25 mg\",\n+            \"light\": \"100-200 mg\",\n+            \"common\": \"200-400 mg\",\n+            \"strong\": \"400-700 mg\",\n+            \"heavy\": \"700+ mg\"\n+          }\n+        }\n+      ]\n+    },\n+    \"duration\": {\n+      \"routes_of_administration\": [\n+        {\n+          \"route\": \"oral\",\n+          \"stages\": {\n+            \"total_duration\": \"3-10 hours\",\n+            \"onset\": \"30-90 minutes\",\n+            \"peak\": \"1-4 hours\",\n+            \"offset\": \"2-6 hours\",\n+            \"after_effects\": \"Up to 24 hours\"\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n+        }\n+      ]\n+    },\n+    \"addiction_potential\": \"Diphenhydramine has low abuse potential due to its overwhelmingly dysphoric and unpleasant effects. While physical dependence is possible with chronic use, most users do not wish to repeat the experience. Tolerance develops rapidly with repeated use.\",\n+    \"interactions\": {\n+      \"dangerous\": [\n+        \"MAOIs (risk of severe anticholinergic effects)\",\n+        \"Anticholinergics (severe tachycardia, heart attack risk, abnormal heart rhythm)\",\n+        \"High doses of acetaminophen-containing formulations (liver damage, death)\"\n+      ],\n+      \"unsafe\": [\n+        \"Stimulants (severe tachycardia, heart attack risk, abnormal heart rhythm)\",\n+        \"Tramadol (increased seizure risk)\",\n+        \"Alcohol (dangerous sedation, respiratory depression)\"\n+      ],\n+      \"caution\": [\n+        \"Benzodiazepines (dangerous sedation, respiratory depression, visual suppression)\",\n+        \"SSRIs (visual suppression, potential serotonin syndrome)\",\n+        \"Opioids (increased sedation, respiratory depression)\"\n+      ]\n+    },\n+    \"notes\": \"Diphenhydramine is widely available over-the-counter and used medically for allergies and sleep aid. Recreational use produces intensely dysphoric and unpredictable deliriant effects including realistic hallucinations that users cannot distinguish from reality. The substance has significant cardiovascular risks including QT prolongation and potential for torsades de pointes. Always verify that products contain only diphenhydramine as active ingredient; many combination products contain acetaminophen or other drugs that can be fatal in high doses. A sober trip sitter is essential as users may respond to hallucinations and injure themselves. Chronic use may cause persistent cognitive impairment, memory damage, and has been linked to increased dementia risk.\",\n+    \"subjective_effects\": [\n+      \"Sedation and Body Heaviness\",\n+      \"External Hallucinations (People, Objects, Insects)\",\n+      \"Auditory Hallucinations (Voices, Screams)\",\n+      \"Tactile Hallucinations (Phantom Sensations)\",\n+      \"Shadow People\",\n+      \"Delirium and Confusion\",\n+      \"Memory Suppression and Amnesia\",\n+      \"Dysphoria and Anxiety\",\n+      \"Restless Leg Syndrome\",\n+      \"Dry Mouth and Dehydration\",\n+      \"Visual Acuity Suppression (Blurred Vision)\",\n+      \"Thought Disorganization\"\n+    ],\n+    \"tolerance\": {\n+      \"full_tolerance\": \"After 2-3 consecutive days of use\",\n+      \"half_tolerance\": \"3-5 days\",\n+      \"zero_tolerance\": \"1-2 weeks\",\n+      \"cross_tolerances\": [\n+        \"All deliriants (datura, scopolamine, dimenhydrinate)\"\n+      ]\n+    },\n+    \"half_life\": \"5 hours (pediatric); 9 hours (adult); 13.5 hours (elderly)\",\n+    \"citations\": [\n+      {\n+        \"name\": \"Erowid Diphenhydramine Vault\",\n+        \"reference\": \"https://www.erowid.org/pharms/diphenhydramine/\"\n+      },\n+      {\n+        \"name\": \"PsychonautWiki: Diphenhydramine\",\n+        \"reference\": \"https://psychonautwiki.org/wiki/Diphenhydramine\"\n+      },\n+      {\n+        \"name\": \"TripSit Wiki: Diphenhydramine\",\n+        \"reference\": \"https://wiki.tripsit.me/wiki/Diphenhydramine\"\n+      },\n+      {\n+        \"name\": \"Bluelight: Diphenhydramine Discussion\",\n+        \"reference\": \"https://www.bluelight.org/community/threads/dph-trip.560305/\"\n+      },\n+      {\n+        \"name\": \"DrugBank: Diphenhydramine\",\n+        \"reference\": \"https://go.drugbank.com/drugs/DB01075\"\n+      },\n+      {\n+        \"name\": \"StatPearls: Diphenhydramine Toxicity\",\n+        \"reference\": \"https://www.ncbi.nlm.nih.gov/books/NBK557578/\"\n+      },\n+      {\n+        \"name\": \"Gray et al., 2015 - Cumulative Anticholinergic Use and Dementia\",\n+        \"reference\": \"https://pubmed.ncbi.nlm.nih.gov/25621434/\"\n+      }\n+    ],\n+    \"categories\": [\n+      \"deliriant\",\n+      \"depressant\",\n+      \"antihistamine\",\n+      \"otc\"\n+    ]\n+  },\n+  \"id\": 627\n+}",
    "submittedBy": "JOSIE"
  },
  {
    "id": "20251016-211713-87b4367c",
    "createdAt": "2025-10-16T21:17:13.242Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 23:17:09"
    },
    "articles": [
      {
        "id": 191,
        "title": "LSD",
        "slug": "lsd"
      }
    ],
    "markdown": "# LSD · #191\n\n-    \"chemical_name\": \"LSD\",\n-    \"alternative_name\": \"Lysergic acid diethylamide\",\n+    \"chemical_name\": \"Lysergic acid diethylamide\",\n+    \"alternative_name\": \"Lucy; Acid\",\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"research-chemical\"\n+      \"common\"",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-210951-3bc6b2e2",
    "createdAt": "2025-10-16T21:09:51.985Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 23:09:48"
    },
    "articles": [
      {
        "id": 242,
        "title": "Gaboxadol",
        "slug": "gaboxadol"
      },
      {
        "id": 176,
        "title": "Zopiclone",
        "slug": "zopiclone"
      },
      {
        "id": 179,
        "title": "Zaleplon",
        "slug": "zaleplon"
      },
      {
        "id": 183,
        "title": "Zolpidem",
        "slug": "zolpidem"
      },
      {
        "id": 200,
        "title": "Psilocybin mushrooms",
        "slug": "psilocybin-mushrooms"
      },
      {
        "id": 201,
        "title": "Amanita Muscaria",
        "slug": "amanita-muscaria"
      },
      {
        "id": 215,
        "title": "Ibotenic acid",
        "slug": "ibotenic-acid"
      },
      {
        "id": 409,
        "title": "Salvia",
        "slug": "salvia"
      }
    ],
    "markdown": "# Gaboxadol · #242\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zopiclone · #176\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zaleplon · #179\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zolpidem · #183\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Psilocybin mushrooms · #200\n\n-  \"title\": \"Penis Envy\",\n+  \"title\": \"Psilocybin mushrooms\",\n-    \"drug_name\": \"Penis Envy\",\n-    \"chemical_name\": \"Penis Envy\",\n-    \"alternative_name\": \"Psilocybe cubensis, Penis Envy strain\",\n+    \"drug_name\": \"Psilocybin mushrooms\",\n+    \"chemical_name\": \"Psilocybin\",\n+    \"alternative_name\": \"Psilocybe cubensis; Magic mushrooms; Shrooms\",\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"research-chemical\"\n+      \"common\"\n\n# Amanita Muscaria · #201\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-          \"canonical_routes\": [\n-            \"smoked\"\n-          ],\n+            \"total_duration\": \"6-8 hours\",\n+            \"onset\": \"30-120 minutes\",\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"smoked\"\n+          ]\n-      \"research-chemical\"\n+      \"research-chemical\",\n+      \"A-typical Hallucinogen\"\n\n# Ibotenic acid · #215\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Salvia · #409\n\n-          \"canonical_routes\": [\n-            \"smoked\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"smoked\"\n+          ]\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"other dissociatives\"\n+      \"other dissociatives\",\n+      \"A-typical Hallucinogen\"",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-210536-524a89f5",
    "createdAt": "2025-10-16T21:05:36.034Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 23:05:33"
    },
    "articles": [
      {
        "id": 242,
        "title": "Gaboxadol",
        "slug": "gaboxadol"
      },
      {
        "id": 176,
        "title": "Zopiclone",
        "slug": "zopiclone"
      },
      {
        "id": 179,
        "title": "Zaleplon",
        "slug": "zaleplon"
      },
      {
        "id": 183,
        "title": "Zolpidem",
        "slug": "zolpidem"
      },
      {
        "id": 201,
        "title": "Amanita Muscaria",
        "slug": "amanita-muscaria"
      },
      {
        "id": 215,
        "title": "Ibotenic acid",
        "slug": "ibotenic-acid"
      },
      {
        "id": 409,
        "title": "Salvia",
        "slug": "salvia"
      }
    ],
    "markdown": "# Gaboxadol · #242\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zopiclone · #176\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zaleplon · #179\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zolpidem · #183\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Amanita Muscaria · #201\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-          \"canonical_routes\": [\n-            \"smoked\"\n-          ],\n+            \"total_duration\": \"6-8 hours\",\n+            \"onset\": \"30-120 minutes\",\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"smoked\"\n+          ]\n-      \"research-chemical\"\n+      \"research-chemical\",\n+      \"A-typical Hallucinogen\"\n\n# Ibotenic acid · #215\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Salvia · #409\n\n-          \"canonical_routes\": [\n-            \"smoked\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"smoked\"\n+          ]\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"other dissociatives\"\n+      \"other dissociatives\",\n+      \"A-typical Hallucinogen\"",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-210425-092f4def",
    "createdAt": "2025-10-16T21:04:25.208Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 23:04:21"
    },
    "articles": [
      {
        "id": 242,
        "title": "Gaboxadol",
        "slug": "gaboxadol"
      },
      {
        "id": 176,
        "title": "Zopiclone",
        "slug": "zopiclone"
      },
      {
        "id": 179,
        "title": "Zaleplon",
        "slug": "zaleplon"
      },
      {
        "id": 183,
        "title": "Zolpidem",
        "slug": "zolpidem"
      },
      {
        "id": 215,
        "title": "Ibotenic acid",
        "slug": "ibotenic-acid"
      },
      {
        "id": 409,
        "title": "Salvia",
        "slug": "salvia"
      }
    ],
    "markdown": "# Gaboxadol · #242\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zopiclone · #176\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zaleplon · #179\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zolpidem · #183\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Ibotenic acid · #215\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Salvia · #409\n\n-          \"canonical_routes\": [\n-            \"smoked\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"smoked\"\n+          ]\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"other dissociatives\"\n+      \"other dissociatives\",\n+      \"A-typical Hallucinogen\"",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-210204-b30f4dee",
    "createdAt": "2025-10-16T21:02:04.651Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 23:02:01"
    },
    "articles": [
      {
        "id": 242,
        "title": "Gaboxadol",
        "slug": "gaboxadol"
      },
      {
        "id": 176,
        "title": "Zopiclone",
        "slug": "zopiclone"
      },
      {
        "id": 179,
        "title": "Zaleplon",
        "slug": "zaleplon"
      },
      {
        "id": 183,
        "title": "Zolpidem",
        "slug": "zolpidem"
      },
      {
        "id": 409,
        "title": "Salvia",
        "slug": "salvia"
      }
    ],
    "markdown": "# Gaboxadol · #242\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zopiclone · #176\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zaleplon · #179\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zolpidem · #183\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Salvia · #409\n\n-          \"canonical_routes\": [\n-            \"smoked\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"smoked\"\n+          ]\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"other dissociatives\"\n+      \"other dissociatives\",\n+      \"A-typical Hallucinogen\"",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-210000-f6e22140",
    "createdAt": "2025-10-16T21:00:00.495Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 22:59:57"
    },
    "articles": [
      {
        "id": 176,
        "title": "Zopiclone",
        "slug": "zopiclone"
      },
      {
        "id": 179,
        "title": "Zaleplon",
        "slug": "zaleplon"
      },
      {
        "id": 183,
        "title": "Zolpidem",
        "slug": "zolpidem"
      },
      {
        "id": 409,
        "title": "Salvia",
        "slug": "salvia"
      }
    ],
    "markdown": "# Zopiclone · #176\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zaleplon · #179\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zolpidem · #183\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Salvia · #409\n\n-          \"canonical_routes\": [\n-            \"smoked\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"smoked\"\n+          ]\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"other dissociatives\"\n+      \"other dissociatives\",\n+      \"A-typical Hallucinogen\"",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-205923-297a11ac",
    "createdAt": "2025-10-16T20:59:23.332Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 22:59:20"
    },
    "articles": [
      {
        "id": 176,
        "title": "Zopiclone",
        "slug": "zopiclone"
      },
      {
        "id": 179,
        "title": "Zaleplon",
        "slug": "zaleplon"
      },
      {
        "id": 183,
        "title": "Zolpidem",
        "slug": "zolpidem"
      }
    ],
    "markdown": "# Zopiclone · #176\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zaleplon · #179\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zolpidem · #183\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-205842-8929e224",
    "createdAt": "2025-10-16T20:58:42.976Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 22:58:39"
    },
    "articles": [
      {
        "id": 176,
        "title": "Zopiclone",
        "slug": "zopiclone"
      },
      {
        "id": 183,
        "title": "Zolpidem",
        "slug": "zolpidem"
      }
    ],
    "markdown": "# Zopiclone · #176\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"\n\n# Zolpidem · #183\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-205804-77914f41",
    "createdAt": "2025-10-16T20:58:04.237Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 22:58:00"
    },
    "articles": [
      {
        "id": 176,
        "title": "Zopiclone",
        "slug": "zopiclone"
      }
    ],
    "markdown": "# Zopiclone · #176\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"gabaergic\"\n+      \"gabaergic\",\n+      \"A-typical Hallucinogen\"",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-204349-778df3a1",
    "createdAt": "2025-10-16T20:43:49.406Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 22:43:45"
    },
    "articles": [
      {
        "id": 59,
        "title": "Mescaline",
        "slug": "mescaline"
      },
      {
        "id": 60,
        "title": "5-MeO-DMT",
        "slug": "5-meo-dmt"
      },
      {
        "id": 73,
        "title": "4-HO-MET",
        "slug": "4-ho-met"
      },
      {
        "id": 79,
        "title": "EA-3167",
        "slug": "ea-3167"
      },
      {
        "id": 82,
        "title": "25I-NBOMe",
        "slug": "25i-nbome"
      },
      {
        "id": 102,
        "title": "4-AcO-DMT",
        "slug": "4-aco-dmt"
      },
      {
        "id": 106,
        "title": "Canket",
        "slug": "canket"
      },
      {
        "id": 107,
        "title": "FXE",
        "slug": "fxe"
      },
      {
        "id": 270,
        "title": "MAL",
        "slug": "mal"
      },
      {
        "id": 514,
        "title": "2C-BZ",
        "slug": "2c-bz"
      },
      {
        "id": 139,
        "title": "DOM",
        "slug": "dom"
      },
      {
        "id": 280,
        "title": "DOB",
        "slug": "dob"
      },
      {
        "id": 158,
        "title": "PMA",
        "slug": "pma"
      },
      {
        "id": 181,
        "title": "DiPT",
        "slug": "dipt"
      },
      {
        "id": 189,
        "title": "DXM Polistirex",
        "slug": "dxm-polistirex"
      },
      {
        "id": 191,
        "title": "LSD",
        "slug": "lsd"
      },
      {
        "id": 196,
        "title": "Ibogaine",
        "slug": "ibogaine"
      },
      {
        "id": 199,
        "title": "Yopo",
        "slug": "yopo"
      },
      {
        "id": 200,
        "title": "Penis Envy",
        "slug": "penis-envy"
      },
      {
        "id": 205,
        "title": "Bromo-DragonFLY",
        "slug": "bromo-dragonfly"
      },
      {
        "id": 206,
        "title": "Kratom",
        "slug": "kratom"
      },
      {
        "id": 201,
        "title": "Amanita Muscaria",
        "slug": "amanita-muscaria"
      },
      {
        "id": 215,
        "title": "Ibotenic acid",
        "slug": "ibotenic-acid"
      },
      {
        "id": 222,
        "title": "DOET",
        "slug": "doet"
      },
      {
        "id": 80,
        "title": "3-Quinuclidinyl benzilate",
        "slug": "3-quinuclidinyl-benzilate"
      },
      {
        "id": 346,
        "title": "Tilmetamine",
        "slug": "tilmetamine"
      },
      {
        "id": 239,
        "title": "2C-N",
        "slug": "2c-n"
      },
      {
        "id": 515,
        "title": "25T-2-NBOMe",
        "slug": "25t-2-nbome"
      },
      {
        "id": 263,
        "title": "DOC",
        "slug": "doc"
      },
      {
        "id": 266,
        "title": "TMA",
        "slug": "tma"
      },
      {
        "id": 264,
        "title": "2C-F",
        "slug": "2c-f"
      },
      {
        "id": 351,
        "title": "2-Chloroephenidine",
        "slug": "2-chloroephenidine"
      },
      {
        "id": 368,
        "title": "3,4-MD-PCP",
        "slug": "3-4-md-pcp"
      },
      {
        "id": 49,
        "title": "ALEPH",
        "slug": "aleph"
      },
      {
        "id": 268,
        "title": "ALEPH-2",
        "slug": "aleph-2"
      },
      {
        "id": 138,
        "title": "AMT",
        "slug": "amt"
      },
      {
        "id": 273,
        "title": "2C-P",
        "slug": "2c-p"
      },
      {
        "id": 276,
        "title": "3-HO-PCP",
        "slug": "3-ho-pcp"
      },
      {
        "id": 281,
        "title": "2C-EF",
        "slug": "2c-ef"
      },
      {
        "id": 285,
        "title": "DMT",
        "slug": "dmt"
      },
      {
        "id": 289,
        "title": "O-PCE",
        "slug": "o-pce"
      },
      {
        "id": 290,
        "title": "DMXE",
        "slug": "dmxe"
      },
      {
        "id": 257,
        "title": "DOEF",
        "slug": "doef"
      },
      {
        "id": 292,
        "title": "25CN-NBOH",
        "slug": "25cn-nboh"
      },
      {
        "id": 293,
        "title": "HXE",
        "slug": "hxe"
      },
      {
        "id": 295,
        "title": "2C-D",
        "slug": "2c-d"
      },
      {
        "id": 311,
        "title": "Cannabis",
        "slug": "cannabis"
      },
      {
        "id": 156,
        "title": "4-Methylthioamphetamine",
        "slug": "4-methylthioamphetamine"
      },
      {
        "id": 321,
        "title": "2C-C",
        "slug": "2c-c"
      },
      {
        "id": 326,
        "title": "DPT",
        "slug": "dpt"
      },
      {
        "id": 329,
        "title": "4-HO-PiPT",
        "slug": "4-ho-pipt"
      },
      {
        "id": 508,
        "title": "4-MeO-MiPT",
        "slug": "4-meo-mipt"
      },
      {
        "id": 338,
        "title": "4-HO-McPT",
        "slug": "4-ho-mcpt"
      },
      {
        "id": 392,
        "title": "2C-T-21",
        "slug": "2c-t-21"
      },
      {
        "id": 182,
        "title": "Sernyl",
        "slug": "sernyl"
      },
      {
        "id": 44,
        "title": "Dextromethorphan",
        "slug": "dextromethorphan"
      },
      {
        "id": 62,
        "title": "MDA",
        "slug": "mda"
      },
      {
        "id": 353,
        "title": "Ephenidine",
        "slug": "ephenidine"
      },
      {
        "id": 359,
        "title": "3-HO-PCE",
        "slug": "3-ho-pce"
      },
      {
        "id": 371,
        "title": "5-MeO-DPT",
        "slug": "5-meo-dpt"
      },
      {
        "id": 375,
        "title": "1B-LSD",
        "slug": "1b-lsd"
      },
      {
        "id": 401,
        "title": "2C-iP",
        "slug": "2c-ip"
      },
      {
        "id": 409,
        "title": "Salvia",
        "slug": "salvia"
      },
      {
        "id": 412,
        "title": "AL-LAD",
        "slug": "al-lad"
      },
      {
        "id": 425,
        "title": "5-MeO-DiBF",
        "slug": "5-meo-dibf"
      },
      {
        "id": 460,
        "title": "Scopolamine",
        "slug": "scopolamine"
      },
      {
        "id": 485,
        "title": "LSZ",
        "slug": "lsz"
      },
      {
        "id": 424,
        "title": "2-Me-DMT",
        "slug": "2-me-dmt"
      },
      {
        "id": 507,
        "title": "25P-NBOMe",
        "slug": "25p-nbome"
      },
      {
        "id": 518,
        "title": "2C-T-4-NBOMe",
        "slug": "2c-t-4-nbome"
      },
      {
        "id": 519,
        "title": "2C-T-7-NBOMe",
        "slug": "2c-t-7-nbome"
      },
      {
        "id": 531,
        "title": "25H-NBOMe",
        "slug": "25h-nbome"
      },
      {
        "id": 526,
        "title": "25I-NBMD",
        "slug": "25i-nbmd"
      },
      {
        "id": 528,
        "title": "25I-NBF",
        "slug": "25i-nbf"
      },
      {
        "id": 529,
        "title": "25I-NBOH",
        "slug": "25i-nboh"
      },
      {
        "id": 534,
        "title": "25C-NB3OMe",
        "slug": "25c-nb3ome"
      },
      {
        "id": 538,
        "title": "2-MeO-Ketamine",
        "slug": "2-meo-ketamine"
      },
      {
        "id": 539,
        "title": "2-MeO-DMT",
        "slug": "2-meo-dmt"
      },
      {
        "id": 540,
        "title": "2C-T-7",
        "slug": "2c-t-7"
      },
      {
        "id": 543,
        "title": "2C-B-FLY-NBOMe",
        "slug": "2c-b-fly-nbome"
      },
      {
        "id": 552,
        "title": "DCK",
        "slug": "dck"
      },
      {
        "id": 560,
        "title": "2-TFMXP",
        "slug": "2-tfmxp"
      },
      {
        "id": 570,
        "title": "4F-MDMB-BINACA",
        "slug": "4f-mdmb-binaca"
      },
      {
        "id": 583,
        "title": "AM-694",
        "slug": "am-694"
      },
      {
        "id": 584,
        "title": "ADBICA",
        "slug": "adbica"
      },
      {
        "id": 589,
        "title": "AMB-CHMICA",
        "slug": "amb-chmica"
      },
      {
        "id": 590,
        "title": "AMB-FUBINACA",
        "slug": "amb-fubinaca"
      },
      {
        "id": 594,
        "title": "CBNA",
        "slug": "cbna"
      },
      {
        "id": 597,
        "title": "Bufotenin",
        "slug": "bufotenin"
      },
      {
        "id": 599,
        "title": "Atropine",
        "slug": "atropine"
      },
      {
        "id": 600,
        "title": "AM-1248",
        "slug": "am-1248"
      },
      {
        "id": 605,
        "title": "25T-NBOMe",
        "slug": "25t-nbome"
      },
      {
        "id": 607,
        "title": "ADB-PINACA",
        "slug": "adb-pinaca"
      },
      {
        "id": 608,
        "title": "ADB-PINACA isomer 2",
        "slug": "adb-pinaca-isomer-2"
      },
      {
        "id": 609,
        "title": "AM-2201",
        "slug": "am-2201"
      },
      {
        "id": 611,
        "title": "BDCK",
        "slug": "bdck"
      },
      {
        "id": 616,
        "title": "AKB-57",
        "slug": "akb-57"
      },
      {
        "id": 622,
        "title": "4-MXP",
        "slug": "4-mxp"
      }
    ],
    "markdown": "# Mescaline · #59\n\n-      \"a-typical hallucinogen\",\n\n# 5-MeO-DMT · #60\n\n-      \"a-typical hallucinogen\",\n\n# 4-HO-MET · #73\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# EA-3167 · #79\n\n-      \"a-typical hallucinogen\",\n\n# 25I-NBOMe · #82\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 4-AcO-DMT · #102\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# Canket · #106\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# FXE · #107\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# MAL · #270\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2C-BZ · #514\n\n-      \"a-typical hallucinogen\",\n\n# DOM · #139\n\n-      \"a-typical hallucinogen\",\n\n# DOB · #280\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# PMA · #158\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# DiPT · #181\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# DXM Polistirex · #189\n\n-      \"a-typical hallucinogen\",\n\n# LSD · #191\n\n-      \"a-typical hallucinogen\",\n\n# Ibogaine · #196\n\n-      \"a-typical hallucinogen\",\n\n# Yopo · #199\n\n-      \"a-typical hallucinogen\",\n\n# Penis Envy · #200\n\n-      \"a-typical hallucinogen\",\n\n# Bromo-DragonFLY · #205\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# Kratom · #206\n\n-      \"a-typical hallucinogen\",\n\n# Amanita Muscaria · #201\n\n-      \"a-typical hallucinogen\",\n\n# Ibotenic acid · #215\n\n-      \"gabaergic\",\n-      \"A-typical hallucinogen\"\n+      \"gabaergic\"\n\n# DOET · #222\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 3-Quinuclidinyl benzilate · #80\n\n-      \"a-typical hallucinogen\",\n\n# Tilmetamine · #346\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2C-N · #239\n\n-      \"a-typical hallucinogen\",\n\n# 25T-2-NBOMe · #515\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# DOC · #263\n\n-      \"stimulant\",\n-      \"a-typical hallucinogen\"\n+      \"stimulant\"\n\n# TMA · #266\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2C-F · #264\n\n-      \"a-typical hallucinogen\",\n\n# 2-Chloroephenidine · #351\n\n-      \"a-typical hallucinogen\",\n\n# 3,4-MD-PCP · #368\n\n-      \"a-typical hallucinogen\",\n\n# ALEPH · #49\n\n-      \"stimulant\",\n-      \"a-typical hallucinogen\"\n+      \"stimulant\"\n\n# ALEPH-2 · #268\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# AMT · #138\n\n-      \"a-typical hallucinogen\",\n\n# 2C-P · #273\n\n-      \"a-typical hallucinogen\",\n\n# 3-HO-PCP · #276\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2C-EF · #281\n\n-      \"a-typical hallucinogen\",\n\n# DMT · #285\n\n-      \"a-typical hallucinogen\",\n\n# O-PCE · #289\n\n-      \"habit-forming\",\n-      \"a-typical hallucinogen\"\n+      \"habit-forming\"\n\n# DMXE · #290\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# DOEF · #257\n\n-      \"a-typical hallucinogen\",\n\n# 25CN-NBOH · #292\n\n-      \"a-typical hallucinogen\",\n\n# HXE · #293\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2C-D · #295\n\n-      \"a-typical hallucinogen\",\n\n# Cannabis · #311\n\n-      \"habit-forming\",\n-      \"a-typical hallucinogen\"\n+      \"habit-forming\"\n\n# 4-Methylthioamphetamine · #156\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2C-C · #321\n\n-      \"a-typical hallucinogen\",\n\n# DPT · #326\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 4-HO-PiPT · #329\n\n-      \"a-typical hallucinogen\",\n\n# 4-MeO-MiPT · #508\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 4-HO-McPT · #338\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2C-T-21 · #392\n\n-      \"a-typical hallucinogen\",\n\n# Sernyl · #182\n\n-      \"a-typical hallucinogen\",\n\n# Dextromethorphan · #44\n\n-      \"a-typical hallucinogen\",\n\n# MDA · #62\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# Ephenidine · #353\n\n-      \"a-typical hallucinogen\",\n\n# 3-HO-PCE · #359\n\n-      \"a-typical hallucinogen\",\n\n# 5-MeO-DPT · #371\n\n-      \"a-typical hallucinogen\",\n\n# 1B-LSD · #375\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2C-iP · #401\n\n-      \"a-typical hallucinogen\",\n\n# Salvia · #409\n\n-      \"A-typical hallucinogen\",\n\n# AL-LAD · #412\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 5-MeO-DiBF · #425\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# Scopolamine · #460\n\n-      \"deliriant\",\n-      \"a-typical hallucinogen\"\n+      \"deliriant\"\n\n# LSZ · #485\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2-Me-DMT · #424\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 25P-NBOMe · #507\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2C-T-4-NBOMe · #518\n\n-      \"a-typical hallucinogen\",\n\n# 2C-T-7-NBOMe · #519\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 25H-NBOMe · #531\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 25I-NBMD · #526\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 25I-NBF · #528\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 25I-NBOH · #529\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 25C-NB3OMe · #534\n\n-      \"a-typical hallucinogen\",\n\n# 2-MeO-Ketamine · #538\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2-MeO-DMT · #539\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 2C-T-7 · #540\n\n-      \"a-typical hallucinogen\",\n\n# 2C-B-FLY-NBOMe · #543\n\n-      \"a-typical hallucinogen\",\n\n# DCK · #552\n\n-      \"a-typical hallucinogen\",\n\n# 2-TFMXP · #560\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# 4F-MDMB-BINACA · #570\n\n-      \"habit-forming\",\n-      \"a-typical hallucinogen\"\n+      \"habit-forming\"\n\n# AM-694 · #583\n\n-      \"a-typical hallucinogen\",\n\n# ADBICA · #584\n\n-      \"depressant\",\n-      \"a-typical hallucinogen\"\n+      \"depressant\"\n\n# AMB-CHMICA · #589\n\n-      \"a-typical hallucinogen\",\n\n# AMB-FUBINACA · #590\n\n-      \"a-typical hallucinogen\",\n\n# CBNA · #594\n\n-      \"nootropic\",\n-      \"a-typical hallucinogen\"\n+      \"nootropic\"\n\n# Bufotenin · #597\n\n-      \"a-typical hallucinogen\",\n\n# Atropine · #599\n\n-      \"deliriant\",\n-      \"a-typical hallucinogen\"\n+      \"deliriant\"\n\n# AM-1248 · #600\n\n-      \"a-typical hallucinogen\",\n\n# 25T-NBOMe · #605\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# ADB-PINACA · #607\n\n-      \"habit-forming\",\n-      \"a-typical hallucinogen\"\n+      \"habit-forming\"\n\n# ADB-PINACA isomer 2 · #608\n\n-      \"a-typical hallucinogen\",\n\n# AM-2201 · #609\n\n-      \"a-typical hallucinogen\",\n\n# BDCK · #611\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"\n\n# AKB-57 · #616\n\n-      \"a-typical hallucinogen\",\n\n# 4-MXP · #622\n\n-      \"research-chemical\",\n-      \"a-typical hallucinogen\"\n+      \"research-chemical\"",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-191133-9b6f5ac8",
    "createdAt": "2025-10-16T19:11:33.130Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 21:11:30"
    },
    "articles": [
      {
        "id": 514,
        "title": "2C-BZ",
        "slug": "2c-bz"
      },
      {
        "id": 321,
        "title": "2C-C",
        "slug": "2c-c"
      }
    ],
    "markdown": "# 2C-BZ · #514\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"a-typical hallucinogen\",\n\n# 2C-C · #321\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-          \"canonical_routes\": [\n-            \"insufflated\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"insufflated\"\n+          ]\n-      \"a-typical hallucinogen\",",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-191042-5c6a6d64",
    "createdAt": "2025-10-16T19:10:42.055Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 21:10:39"
    },
    "articles": [
      {
        "id": 514,
        "title": "2C-BZ",
        "slug": "2c-bz"
      }
    ],
    "markdown": "# 2C-BZ · #514\n\n-          \"canonical_routes\": [\n-            \"oral\"\n-          ],\n-          }\n+          },\n+          \"canonical_routes\": [\n+            \"oral\"\n+          ]\n-      \"a-typical hallucinogen\",",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-190938-8a5873a8",
    "createdAt": "2025-10-16T19:09:38.185Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 16/10/2025, 21:09:35"
    },
    "articles": [],
    "markdown": "No diff details were provided for this commit.",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251016-083502-09318c26",
    "createdAt": "2025-10-16T08:35:02.514Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/16/2025, 2:35:00 AM"
    },
    "articles": [
      {
        "id": 36,
        "title": "Trazodone",
        "slug": "trazodone"
      },
      {
        "id": 86,
        "title": "Tranylcypromine",
        "slug": "tranylcypromine"
      },
      {
        "id": 144,
        "title": "Phenelzine",
        "slug": "phenelzine"
      },
      {
        "id": 186,
        "title": "Vilazodone",
        "slug": "vilazodone"
      },
      {
        "id": 303,
        "title": "Ondansetron",
        "slug": "ondansetron"
      },
      {
        "id": 302,
        "title": "Moclobemide",
        "slug": "moclobemide"
      },
      {
        "id": 301,
        "title": "Quetiapine",
        "slug": "quetiapine"
      },
      {
        "id": 307,
        "title": "Tianeptine",
        "slug": "tianeptine"
      },
      {
        "id": 374,
        "title": "Lean",
        "slug": "lean"
      },
      {
        "id": 430,
        "title": "Olanzapine",
        "slug": "olanzapine"
      },
      {
        "id": 442,
        "title": "Clobenzorex",
        "slug": "clobenzorex"
      },
      {
        "id": 458,
        "title": "Chlorpheniramine",
        "slug": "chlorpheniramine"
      },
      {
        "id": 530,
        "title": "Ro5-4864",
        "slug": "ro5-4864"
      }
    ],
    "markdown": "# Trazodone · #36\n\n-    \"psychoactive_class\": \"Antidepressant (Serotonin Antagonist and Reuptake Inhibitor, SARI)\",\n+    \"psychoactive_class\": \"Antidepressant\",\n\n# Tranylcypromine · #86\n\n-    \"psychoactive_class\": \"Antidepressant (Monoamine Oxidase Inhibitor, MAOI)\",\n+    \"psychoactive_class\": \"Antidepressant\",\n\n# Phenelzine · #144\n\n-    \"psychoactive_class\": \"Antidepressant (Monoamine Oxidase Inhibitor, MAOI)\",\n+    \"psychoactive_class\": \"Antidepressant\",\n\n# Vilazodone · #186\n\n-    \"psychoactive_class\": \"Antidepressant (Selective Serotonin Reuptake Inhibitor and 5-HT1A receptor partial agonist)\",\n+    \"psychoactive_class\": \"Antidepressant\",\n\n# Ondansetron · #303\n\n-    \"psychoactive_class\": \"Antiemetic (not psychoactive in the traditional sense, but acts on the central nervous system to prevent nausea/vomiting)\",\n+    \"psychoactive_class\": \"Antiemetic\",\n\n# Moclobemide · #302\n\n-    \"psychoactive_class\": \"Antidepressant (Reversible MAO-A inhibitor)\",\n+    \"psychoactive_class\": \"Antidepressant\",\n\n# Quetiapine · #301\n\n-    \"psychoactive_class\": \"Atypical antipsychotic\",\n+    \"psychoactive_class\": \"Antipsychotic (atypical)\",\n\n# Tianeptine · #307\n\n-    \"psychoactive_class\": \"Full μ-opioid receptor agonist; atypical antidepressant\",\n+    \"psychoactive_class\": \"Full μ-opioid receptor agonist; Antidepressant (atypical)\",\n\n# Lean · #374\n\n-    \"psychoactive_class\": \"Opioid depressant; antihistamine sedative\",\n+    \"psychoactive_class\": \"Opioid depressant; Antihistamine; Sedative\",\n\n# Olanzapine · #430\n\n-    \"psychoactive_class\": \"Atypical antipsychotic (multi-receptor antagonist)\",\n+    \"psychoactive_class\": \"Antipsychotic (atypical)\",\n\n# Clobenzorex · #442\n\n-    \"psychoactive_class\": \"Catecholaminergic stimulant; prodrug that yields d-amphetamine (~15 % conversion)\",\n+    \"psychoactive_class\": \"Stimulant; prodrug that yields d-amphetamine (~15 % conversion)\",\n\n# Chlorpheniramine · #458\n\n-    \"psychoactive_class\": \"Antihistamine (H1 receptor antagonist)\",\n+    \"psychoactive_class\": \"Antihistamine\",\n\n# Ro5-4864 · #530\n\n-    \"psychoactive_class\": \"atypical benzodiazepine; TSPO (18 kDa translocator protein) agonist with weak or absent classical GABA_A activity\",\n+    \"psychoactive_class\": \"Benzodiazepine (atypical); TSPO (18 kDa translocator protein) agonist with weak or absent classical GABA_A activity\",",
    "submittedBy": "JOSIE"
  },
  {
    "id": "20251014-233456-d6536e79",
    "createdAt": "2025-10-14T23:34:56.256Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/14/2025, 5:34:54 PM"
    },
    "articles": [
      {
        "id": 294,
        "title": "Bromantane",
        "slug": "bromantane"
      }
    ],
    "markdown": "### Bromantane · #294\n\n- `drug_info.psychoactive_class`: \"Stimulant actoprotector; anxiolytic nootropic\" → \"Stimulant actoprotector; anxiolytic; nootropic\"",
    "submittedBy": "JOSIE"
  },
  {
    "id": "20251014-233158-373c6f71",
    "createdAt": "2025-10-14T23:31:58.069Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/14/2025, 5:31:55 PM"
    },
    "articles": [
      {
        "id": 152,
        "title": "Dimenhydrinate",
        "slug": "dimenhydrinate"
      },
      {
        "id": 396,
        "title": "Propranolol",
        "slug": "propranolol"
      },
      {
        "id": 417,
        "title": "Avizafone",
        "slug": "avizafone"
      }
    ],
    "markdown": "### Dimenhydrinate · #152\n\n- `drug_info.psychoactive_class`: \"Deliriant (anticholinergic); Antihistamine; Anti-emetic\" → \"Deliriant; Antihistamine; Anti-emetic\"\n\n### Propranolol · #396\n\n- `drug_info.psychoactive_class`: updated long text (98 characters; starts \"Not typically classified as psychoactive; Antihypertensive; antiarrhy...\") → text (\"Not typically classified as psychoactive; Antihypertensive; antiarrhythmic; anxiolytic\")\n\n### Avizafone · #417\n\n- `drug_info.psychoactive_class`: \"Sedative-hypnotic; anxiolytic (benzodiazepine)\" → \"Sedative-hypnotic; anxiolytic\"",
    "submittedBy": "JOSIE"
  },
  {
    "id": "20251013-212828-39bd2cd6",
    "createdAt": "2025-10-13T21:28:28.668Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 13/10/2025, 23:28:26"
    },
    "articles": [
      {
        "id": 595,
        "title": "1cP-MiPLA",
        "slug": "1cp-mipla"
      }
    ],
    "markdown": "### 1cP-MiPLA · #595\n\n- `drug_info.dosages.routes_of_administration[0].dose_ranges.heavy`: \"300 µg +\" → \"300 µg +\"\n- `drug_info.dosages.routes_of_administration[1].dose_ranges.heavy`: \"250 µg +\" → \"250 µg +\"\n- `drug_info.categories[1]`: \"a-typical hallucinogen\" → \"research-chemical\"\n- `drug_info.categories[2]`: removed text (\"research-chemical\")",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251013-212356-370466a5",
    "createdAt": "2025-10-13T21:23:56.596Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 13/10/2025, 23:23:53"
    },
    "articles": [],
    "markdown": "No changelog details were provided for this commit.",
    "submittedBy": "WITCHY"
  },
  {
    "id": "20251013-210154-43d82145",
    "createdAt": "2025-10-13T21:01:54.147Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/13/2025, 3:01:52 PM"
    },
    "articles": [
      {
        "id": 33,
        "title": "3-MeO-PCP",
        "slug": "3-meo-pcp"
      }
    ],
    "markdown": "### 3-MeO-PCP · #33\n\n- `drug_info.alternative_name`: added text (\"3-Methoxyphencyclidine\")",
    "submittedBy": "JOSIE"
  },
  {
    "id": "20251012-120815-ffa8a8d5",
    "createdAt": "2025-10-12T12:08:15.759Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/12/2025, 6:08:14 AM"
    },
    "articles": [
      {
        "id": 510,
        "title": "3-Cl-PCP",
        "slug": "3-cl-pcp"
      }
    ],
    "markdown": "### 3-Cl-PCP · #510\n\n- `drug_info.categories[2]`: removed (was `a-typical hallucinogen`)"
  },
  {
    "id": "20251012-120542-f6e605f4",
    "createdAt": "2025-10-12T12:05:42.088Z",
    "commit": {
      "sha": "",
      "url": "",
      "message": "Dev editor update - 10/12/2025, 6:05:40 AM"
    },
    "articles": [
      {
        "id": 389,
        "title": "3-MeO-PCMo",
        "slug": "3-meo-pcmo"
      }
    ],
    "markdown": "### 3-MeO-PCMo · #389\n\n- `content`: `# 3-MeO-PCMo\n## Arylcyclohexylamine (morpholine subgroup) | Dissociative NMDA-receptor antagonist with mild monoaminergic activity\n      \nPotency is roughly 1/10 of 3-MeO-PCP but still active in double-digit milligram range; weigh on 0.001 g scale and perform 1-3 mg allergy test. Virtually no clinical history: all human data are anecdotal. Reports of confusion, mania and prolonged delirium at heavy doses. Limited reagent-test data; use full panel to rule out NBOMe / opioid adulterants. Crystal often hygroscopic – store in airtight, light-protected container with desiccant.` → ``"
  }
]